Ernest De Paolantonio, a finance veteran with more than 35 years of experience, is the new chief financial officer at BioDelivery Sciences (Nasdaq: BDSI).

The Raleigh-based firm says its current CFO Jim McNulty will assume a new role as senior vice president for finance and treasurer.

The change was announced Monday.

De Paolantonio had served as CEO at CorePharma, a speciality generic company, over the past five years.

“Ernie’s expertise and leadership is going to be extremely valuable as we anticipate the approval and commercialization of our second product, Bunavail, in 2014 and subsequently BEMA Buprenorphine for chronic pain,” said BDSI Chief Executive Officer Mark Sirgo.

“Ernie has built and led the finance departments at both Core and Columbia as both companies approached and subsequently executed commercialization of their products. In addition, Ernie’s expertise in business development and oversight of manufacturing and the supply chain will be invaluable to BDSI as we continue to evolve in those areas. Finally, Ernie has both the background and experience of having played a key role in the evolution of smaller companies into high-growth pharmaceutical businesses that will be particularly useful in his role at BDSI.”